Literature DB >> 27638835

Diagnostic Delay in Crohn's Disease: Time for Red Flags.

Gionata Fiorino1, Silvio Danese2,3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27638835     DOI： 10.1007/s10620-016-4298-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  14 in total

1.  Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

Authors:  Geert D'Haens; Filip Baert; Gert van Assche; Philip Caenepeel; Philippe Vergauwe; Hans Tuynman; Martine De Vos; Sander van Deventer; Larry Stitt; Allan Donner; Severine Vermeire; Frank J Van De Mierop; Jean-Charles R Coche; Janneke van der Woude; Thomas Ochsenkühn; Ad A van Bodegraven; Philippe P Van Hootegem; Guy L Lambrecht; Fazia Mana; Paul Rutgeerts; Brian G Feagan; Daniel Hommes
Journal:  Lancet       Date:  2008-02-23       Impact factor: 79.321

2.  Diagnostic delay in Crohn's disease is associated with increased rate of abdominal surgery: A retrospective study in Chinese patients.

Authors:  Yuan Li; Jianan Ren; Gefei Wang; Guosheng Gu; Xiuwen Wu; Huajian Ren; Zhiwu Hong; Dong Hu; Qin Wu; Guanwei Li; Song Liu; Nadeem Anjum; Jieshou Li
Journal:  Dig Liver Dis       Date:  2015-03-14       Impact factor: 4.088

Review 3.  Catching the therapeutic window of opportunity in early Crohn's disease.

Authors:  Silvio Danese; Gionata Fiorino; Carlos Fernandes; Laureal Peyrin-Biroulet
Journal:  Curr Drug Targets       Date:  2014       Impact factor: 3.465

4.  Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey.

Authors:  Subrata Ghosh; Rod Mitchell
Journal:  J Crohns Colitis       Date:  2007-09       Impact factor: 9.071

5.  Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.

Authors:  Stephan R Vavricka; Sabrina M Spigaglia; Gerhard Rogler; Valérie Pittet; Pierre Michetti; Christian Felley; Christian Mottet; Christian P Braegger; Daniela Rogler; Alex Straumann; Peter Bauerfeind; Michael Fried; Alain M Schoepfer
Journal:  Inflamm Bowel Dis       Date:  2011-04-20       Impact factor: 5.325

6.  Delayed diagnosis is influenced by the clinical pattern of Crohn's disease and affects treatment outcomes and quality of life in the long term: a cross-sectional study of 361 patients in Southern Italy.

Authors:  Gianluca Pellino; Guido Sciaudone; Francesco Selvaggi; Gabriele Riegler
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-02       Impact factor: 2.566

7.  Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort.

Authors:  Kelvin T Thia; William J Sandborn; William S Harmsen; Alan R Zinsmeister; Edward V Loftus
Journal:  Gastroenterology       Date:  2010-07-14       Impact factor: 22.682

8.  Diagnostic Delay Is Associated with a Greater Risk of Early Surgery in a French Cohort of Crohn's Disease Patients.

Authors:  Stéphane Nahon; Pierre Lahmek; Thierry Paupard; Bruno Lesgourgues; Stanislas Chaussade; Laurent Peyrin-Biroulet; Vered Abitbol
Journal:  Dig Dis Sci       Date:  2016-05-20       Impact factor: 3.199

9.  Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.

Authors:  Reena Khanna; Brian Bressler; Barrett G Levesque; Guangyong Zou; Larry W Stitt; Gordon R Greenberg; Remo Panaccione; Alain Bitton; Pierre Paré; Séverine Vermeire; Geert D'Haens; Donald MacIntosh; William J Sandborn; Allan Donner; Margaret K Vandervoort; Joan C Morris; Brian G Feagan
Journal:  Lancet       Date:  2015-09-03       Impact factor: 79.321

10.  Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate.

Authors:  Alain M Schoepfer; Mohamed-Ali Dehlavi; Nicolas Fournier; Ekaterina Safroneeva; Alex Straumann; Valérie Pittet; Laurent Peyrin-Biroulet; Pierre Michetti; Gerhard Rogler; Stephan R Vavricka
Journal:  Am J Gastroenterol       Date:  2013-08-27       Impact factor: 10.864
View more
  6 in total

1.  Time between suspected and confirmed diagnoses of Crohn's disease and ulcerative colitis in patients followed in gastroenterological practices in Germany.

Authors:  Karel Kostev; Marcel Konrad; Louis Jacob
Journal:  Int J Colorectal Dis       Date:  2018-05-02       Impact factor: 2.571

2.  Trends in Biochemical Parameters, Healthcare Resource and Medication Use in the 5 Years Preceding IBD Diagnosis: A Health Maintenance Organization Cohort Study.

Authors:  Nathaniel A Cohen; Efrat Kliper; Noa Zamstein; Tomer Ziv-Baran; Matti Waterman; Gabriel Hodik; Amir Ben Tov; Revital Kariv
Journal:  Dig Dis Sci       Date:  2022-10-11       Impact factor: 3.487

3.  Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease.

Authors:  Sare Verstockt; Bram Verstockt; Kathleen Machiels; Maaike Vancamelbeke; Marc Ferrante; Isabelle Cleynen; Gert De Hertogh; Séverine Vermeire
Journal:  Inflamm Bowel Dis       Date:  2021-10-18       Impact factor: 5.325

4.  The new frontier: Certifying quality standards in the inflammatory bowel disease care.

Authors:  Gionata Fiorino; Silvio Danese
Journal:  United European Gastroenterol J       Date:  2021-07-10       Impact factor: 6.866

5.  Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease.

Authors:  Fernando Rizzello; Ignazio Olivieri; Alessandro Armuzzi; Fabio Ayala; Vincenzo Bettoli; Luca Bianchi; Luca Cimino; Antonio Costanzo; Antonio Cristaudo; Salvatore D'Angelo; Marco Daperno; Anna Chiara Fostini; Mauro Galeazzi; Michele Gilio; Paolo Gionchetti; Paolo Gisondi; Ennio Lubrano; Antonio Marchesoni; Annamaria Offidani; Ambrogio Orlando; Daniela Pugliese; Carlo Salvarani; Raffaele Scarpa; Maurizio Vecchi; Giampiero Girolomoni
Journal:  Adv Ther       Date:  2018-03-07       Impact factor: 3.845

6.  Serum exosomal pregnancy zone protein as a promising biomarker in inflammatory bowel disease.

Authors:  Jing Shao; Yan Jin; Chunhong Shao; Hui Fan; Xiaorui Wang; Guang Yang
Journal:  Cell Mol Biol Lett       Date:  2021-08-10       Impact factor: 5.787
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.